Literature DB >> 1766671

Mutations in the p53 gene in myelodysplastic syndromes.

P Jonveaux1, P Fenaux, I Quiquandon, J M Pignon, J L Laï, M H Loucheux-Lefebvre, M Goossens, F Bauters, R Berger.   

Abstract

We have examined p53 alleles in 151 DNAs from patients with myelodysplastic syndrome using single-strand conformation polymorphism analysis of polymerase chain reaction products. We focused our study on the four highly conserved regions of the p53 gene and detected five patients with aberrantly migrating fragments. We confirmed the putative mutation in each case by direct sequencing analysis. Of these five patients, three had chromosome 17 monosomy associated with p53 mutation, one patient showed one mutated p53 allele and one wild-type allele, and the last patient demonstrated only the mutant allele, suggesting a homozygous state. Unlike many other types of human cancers, point mutations in the p53 tumor-suppressor gene appear to be a rare event in myelodysplastic syndromes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766671

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping.

Authors:  Jun-ichi Miyagi; Naoki Kakazu; Masato Masuda; Takashi Miyagi; Tamiko Toyohama; Tetsuro Nakazato; Takeaki Tomoyose; Tetsuharu Shinjyo; Akitoshi Nagasaki; Naoya Taira; Misao Ohki; Tatsuo Abe; Nobuyuki Takasu
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q).

Authors:  Leonie Saft; Mohsen Karimi; Mehran Ghaderi; András Matolcsy; Ghulam J Mufti; Austin Kulasekararaj; Gudrun Göhring; Aristoteles Giagounidis; Dominik Selleslag; Petra Muus; Guillermo Sanz; Moshe Mittelman; David Bowen; Anna Porwit; Tommy Fu; Jay Backstrom; Pierre Fenaux; Kyle J MacBeth; Eva Hellström-Lindberg
Journal:  Haematologica       Date:  2014-03-28       Impact factor: 9.941

3.  Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

Authors:  D A Sallman; R Komrokji; C Vaupel; T Cluzeau; S M Geyer; K L McGraw; N H Al Ali; J Lancet; M J McGinniss; S Nahas; A E Smith; A Kulasekararaj; G Mufti; A List; J Hall; E Padron
Journal:  Leukemia       Date:  2015-10-30       Impact factor: 11.528

4.  Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.

Authors:  Marta Fernandez-Mercado; Adam Burns; Andrea Pellagatti; Aristoteles Giagounidis; Ulrich Germing; Xabier Agirre; Felipe Prosper; Carlo Aul; Sally Killick; James S Wainscoat; Anna Schuh; Jacqueline Boultwood
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

Review 5.  Chromosome and molecular abnormalities in myelodysplastic syndromes.

Authors:  Pierre Fenaux
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

6.  Increased levels and activity of E2F1 transcription factor in myelodysplastic bone marrow.

Authors:  Gurveen Saberwal; Steven Lucas; Imke Janssen; Avnish Deobhakta; Wen-Yang Hu; Naomi Galili; Azra Raza; Suneel D Mundle
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

7.  A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations.

Authors:  J S Beck; A E Kwitek; P H Cogen; A K Metzger; G M Duyk; V C Sheffield
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

8.  p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.

Authors:  M Kitagawa; S Yoshida; T Kuwata; T Tanizawa; R Kamiyama
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

9.  Linkage mapping of the tumor necrosis factor receptor 2 (TNFR2) gene to 1p36.2 using the single-strand conformation polymorphism technique.

Authors:  B A Kaufman; P S White; T Steinbrueck; H Donis-Keller; G M Brodeur
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

10.  Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.

Authors:  Haiming Xu; Silvia Menendez; Brigitte Schlegelberger; Narae Bae; Peter D Aplan; Gudrun Göhring; Tony R Deblasio; Stephen D Nimer
Journal:  Blood       Date:  2012-08-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.